Literature DB >> 15111311

Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12).

Anna Dahlén1, Christopher D M Fletcher, Fredrik Mertens, Jonathan A Fletcher, Antonio R Perez-Atayde, M John Hicks, Maria Debiec-Rychter, Raf Sciot, Johan Wejde, Rikard Wedin, Nils Mandahl, Ioannis Panagopoulos.   

Abstract

Activation of the GLI oncogene is an important step in the sonic hedgehog signaling pathway, and leads to, eg, tissue-specific cell proliferation during embryogenesis. GLI activity in adult tissues is restricted, but has been identified in various neoplasms, as a result of mutations in the PTCH (patched) or SMOH (smoothened) genes, encoding components of the sonic hedgehog pathway, or by amplification of GLI. Herein, we present a new mechanism of GLI activation through fusion with the beta-actin gene (ACTB) in five histologically distinctive soft tissue tumors showing a t(7;12)(p21-22;q13-15) and a pericytic phenotype. Each was composed of a perivascular proliferation of monomorphic short spindle cells that stained positively for smooth muscle actin and laminin and that showed pericytic features by electron microscopy. To date, with a median follow-up of 24 months, none has behaved in an aggressive manner. Molecular genetic analysis showed that the translocation in all cases resulted in a fusion transcript including the 5'-part of ACTB and the 3'-part of GLI. The DNA-binding zinc finger domains of GLI were retained in the fusion transcripts and it is likely that the replacement of the promoter region of GLI with that of the ubiquitously expressed ACTB gene leads to deregulation of GLI expression and its downstream target genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111311      PMCID: PMC1615655          DOI: 10.1016/s0002-9440(10)63723-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

Review 1.  Contribution of molecular genetic data to the classification of sarcomas.

Authors:  M Ladanyi; J A Bridge
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

2.  Sporadic medulloblastomas contain PTCH mutations.

Authors:  C Raffel; R B Jenkins; L Frederick; D Hebrink; B Alderete; D W Fults; C D James
Journal:  Cancer Res       Date:  1997-03-01       Impact factor: 12.701

3.  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.

Authors:  J Reifenberger; M Wolter; R G Weber; M Megahed; T Ruzicka; P Lichter; G Reifenberger
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

4.  GLI activates transcription through a herpes simplex viral protein 16-like activation domain.

Authors:  J W Yoon; C Z Liu; J T Yang; R Swart; P Iannaccone; D Walterhouse
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

5.  GLI gene expression in bone and soft tissue sarcomas of adult patients correlates with tumor grade.

Authors:  U Stein; C Eder; U Karsten; W Haensch; W Walther; P M Schlag
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

Review 6.  Fusion genes in solid tumors.

Authors:  P Aman
Journal:  Semin Cancer Biol       Date:  1999-08       Impact factor: 15.707

7.  Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.

Authors:  K P O'Brien; E Seroussi; P Dal Cin; R Sciot; N Mandahl; J A Fletcher; C Turc-Carel; J P Dumanski
Journal:  Genes Chromosomes Cancer       Date:  1998-10       Impact factor: 5.006

8.  Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma.

Authors:  M P Simon; F Pedeutour; N Sirvent; J Grosgeorge; F Minoletti; J M Coindre; M J Terrier-Lacombe; N Mandahl; R D Craver; N Blin; G Sozzi; C Turc-Carel; K P O'Brien; D Kedra; I Fransson; C Guilbaud; J P Dumanski
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

9.  Activating Smoothened mutations in sporadic basal-cell carcinoma.

Authors:  J Xie; M Murone; S M Luoh; A Ryan; Q Gu; C Zhang; J M Bonifas; C W Lam; M Hynes; A Goddard; A Rosenthal; E H Epstein; F J de Sauvage
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

10.  Characterization of the promoter region and genomic organization of GLI, a member of the Sonic hedgehog-Patched signaling pathway.

Authors:  C Z Liu; J T Yang; J W Yoon; E Villavicencio; K Pfendler; D Walterhouse; P Iannaccone
Journal:  Gene       Date:  1998-03-16       Impact factor: 3.688

View more
  35 in total

1.  Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.

Authors:  Elspeth M Beauchamp; Lymor Ringer; Gülay Bulut; Kamal P Sajwan; Michael D Hall; Yi-Chien Lee; Daniel Peaceman; Metin Ozdemirli; Olga Rodriguez; Tobey J Macdonald; Chris Albanese; Jeffrey A Toretsky; Aykut Uren
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

2.  Novel MIR143-NOTCH fusions in benign and malignant glomus tumors.

Authors:  Juan-Miguel Mosquera; Andrea Sboner; Lei Zhang; Chun-Liang Chen; Yun-Shao Sung; Hsiao-Wei Chen; Narasimhan P Agaram; Daniel Briskin; Basma M Basha; Samuel Singer; Mark A Rubin; Thomas Tuschl; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2013-09-02       Impact factor: 5.006

3.  A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.

Authors:  Cristina R Antonescu; Narasimhan P Agaram; Yun-Shao Sung; Lei Zhang; David Swanson; Brendan C Dickson
Journal:  Am J Surg Pathol       Date:  2018-04       Impact factor: 6.394

Review 4.  What is new in pericytomatous, myoid, and myofibroblastic tumors?

Authors:  Ivy John; Karen J Fritchie
Journal:  Virchows Arch       Date:  2019-11-08       Impact factor: 4.064

Review 5.  SWI/SNF chromatin remodeling complexes and cancer.

Authors:  Jaclyn A Biegel; Tracy M Busse; Bernard E Weissman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-08-28       Impact factor: 3.908

6.  Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model.

Authors:  Hui-zhi Fan; Hang Liu; Chen Zhang; Dong-mei Gao; Qun Xue; Jun Chen; Rui-xia Sun; Yin-kun Liu; Peng-yuan Yang
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-14       Impact factor: 4.553

7.  GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein.

Authors:  Elspeth Beauchamp; Gulay Bulut; Ogan Abaan; Kevin Chen; Akil Merchant; William Matsui; Yoshimi Endo; Jeffrey S Rubin; Jeffrey Toretsky; Aykut Uren
Journal:  J Biol Chem       Date:  2009-02-03       Impact factor: 5.157

Review 8.  Genomic characteristics of soft tissue sarcomas.

Authors:  Fredrik Mertens; Ioannis Panagopoulos; Nils Mandahl
Journal:  Virchows Arch       Date:  2009-02-03       Impact factor: 4.064

9.  The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of Transcription Factors in Gene Regulation and Diseases.

Authors:  Hu Zhu; Hui-Wen Lo
Journal:  Curr Genomics       Date:  2010-06       Impact factor: 2.236

10.  Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.

Authors:  Matthias Lauth; Asa Bergström; Takashi Shimokawa; Rune Toftgård
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.